National Cancer Institute of the MoH of Ukraine ( Site 0962)

Kyiv, Kyivska Oblast 03022

0 studies enrolling now · 1 studies all time

What they study most

Bladder Cancer

Studies at this site

• Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866) — Completed